SaiAoJin Group is a large-scale multinational medical and health investment group integrating medical universities, cell biology, biopharmaceuticals, oncology chain stores, medical groups, and public welfare and charity.
Guangzhou SaiAoJin Biotechnology Co., Ltd.
Rooted in the innovative hotbed of Guangzhou Nansha International Medical Pilot Zone, it is a high-tech enterprise integrating cell technology research and development, achievement transformation, and industrial application.
It not only has anti-cancer and anti-aging properties, but also promotes cell repair and regeneration, and delays aging.
Sci Tech Innovation Platform
Cell research and development, diagnostic reagents, oncology treatment equipment, stem cell biotechnology research and development center, regenerative functional medicine and anti-aging center, longevity clinic, gut microbiota transplantation (FMT) center, precision health management center, 5G smart health center, and international medical exchange center.
Guangzhou SaiAoJin Biotechnology Co., Ltd. is the strategic core vehicle for the Sino-US Saojin Group to focus on innovative biopharmaceuticals and lay out core R&D and technology transfer. Leveraging the Group's core technological strength accumulated over 30 years in the biopharmaceutical field, its global industrial resources, and cross-regional operational experience, the company focuses on key human health needs such as cancer treatment. It has built a full-chain competitive advantage in biopharmaceuticals and cell therapy, encompassing "R&D-transformation-production-globalization," and is committed to becoming a top-tier biopharmaceutical company with both Chinese innovative genes and a global vision.
